Pharmaceutical Technology· GlobalData Healthcare·· 1 天前AI 评分22
ESMO26：KEYNOTE-C93 支持 Keytruda 无化疗方案用于 dMMR 子宫内膜癌
ESMO26: KEYNOTE-C93 backs chemo-free Keytruda in dMMR endometrial cancer
AI 导读
ESMO26 公布的 KEYNOTE-C93 研究支持 Keytruda 无化疗方案用于 dMMR 子宫内膜癌。该结果在 ESMO26 上公布，为 Keytruda 在 dMMR 子宫内膜癌中免去化疗提供依据。
正文 · 原文
Unlock FREE Access to Premium Content
Discover exclusive forecasts, analyst insights, and in-depth pharmaceutical industry analysis spanning drug development, manufacturing, regulation, and global healthcare trends.
With a free Pharmaceutical Technology profile, you can:
- Access exclusive analyst commentary and expert insights
- View premium forecasts and data-driven pharmaceutical industry insights
- Stay up to date with pharma news, manufacturing innovation, and regulatory developments
- Receive alerts when new premium content is published
Unlock free access
Already have an account? Login here
Powered by
来源：Pharmaceutical Technology · pharmaceutical-technology.com